Series B · BiotechTenpoint Therapeutics: Series BDevelops treatments to rejuvenate vision in the aging eyePublished Oct 4, 2026By RoundOS Funding deskFunding historyJan 29, 2026Series B · This round$235MSourcesbusinesswire.com↗
AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120MSeries C · Aug 27, 2026
ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35MStrategic · Aug 27, 2026
TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25MSeed · Aug 26, 2026
Airway TherapeuticsDevelops biologic therapies for respiratory and infectious diseases$50MSeries E2 · Aug 25, 2026